Bausch Health Companies Inc.
NYSE:BHC
Overview | Financials
Company Name | Bausch Health Companies Inc. |
Symbol | BHC |
Currency | USD |
Price | 7.26 |
Market Cap | 2,670,252,684 |
Dividend Yield | 0% |
52-week-range | 3.96 - 11.46 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Thomas J. Appio |
Website | https://www.bauschhealth.com |
An error occurred while fetching data.
About Bausch Health Companies Inc.
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD